Wir schaffen Wissen – heute für morgen

The Paul Scherrer Institute, PSI, is the largest research institute for natural and engineering sciences within Switzerland. We perform world-class research in three main subject areas: Matter and Material; Energy and the Environment; and Human Health. By conducting fundamental and applied research, we work on long-term solutions for major challenges facing society, industry and science.

Current news from PSI

15 October 2018

teaser picture

30 Jahre Paul Scherrer Institut PSI


Festakt mit geladenen Gästen aus Politik, Wirtschaft und Wissenschaft

Heute fand am Paul Scherrer Institut PSI der Festakt 30 Jahre PSI statt. Das PSI zeigte seinen Gästen auf, was es in den vergangenen drei Jahrzehnten an Ergebnissen hervorgebracht hat, von denen alle in der Schweiz profitieren können.
This news release is only available in German.

11 October 2018

teaser picture

Licence agreement with Swiss pharma firm for development of a cancer drug

Medical Science Human Health Radiopharmacy Industrial co-operation

A radioactive agent, developed at the Paul Scherrer Institute PSI to fight an especially malignant form of thyroid cancer, has the potential to become a blockbuster drug. Due to its structure, it might also be able to dock onto cells of other tumours and destroy them with its radiation. The Lausanne-based biopharmaceutical company Debiopharm wants to further develop the PSI agent to the point where it is approved as a drug. Debiopharm and PSI have now created the contractual basis for this.

10 October 2018

teaser picture

This time, it's all bio: SwissFEL makes protein structures visible

Media Releases Biology Human Health SwissFEL

For the development of new medicinal agents, accurate knowledge of proteins is crucial. In a pilot experiment, researchers have now, for the first time, used the X-ray free-electron laser SwissFEL of PSI for the examination of protein crystals.
Older news can be found in the overview of the current year.